| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US7026337 | ALVOGEN | Antimycotic gel having high active compound release |
Nov, 2016
(7 years ago) | |
| US7018656 | ALVOGEN | Antimycotic gel with high active substance release |
Sep, 2018
(5 years ago) | |
Ciclopirox is owned by Alvogen.
Ciclopirox contains Ciclopirox.
Ciclopirox has a total of 2 drug patents out of which 2 drug patents have expired.
Expired drug patents of Ciclopirox are:
- US7026337
- US7018656
Ciclopirox was authorised for market use on 21 July, 1997.
Ciclopirox is available in gel;topical dosage forms.
Ciclopirox can be used as topical treatment of interdigital tinea pedis and tinea corporis due to trichophyton rubrum, trichophyton mentagrophytes or epidermophyton floccosum.
The generics of Ciclopirox are possible to be released after 05 September, 2018.
Drugs and Companies using CICLOPIROX ingredient
Market Authorisation Date: 21 July, 1997
Treatment: Topical treatment of interdigital tinea pedis and tinea corporis due to trichophyton rubrum, trichophyton mentagrophytes or epidermophyton floccosum
Dosage: GEL;TOPICAL
CICLOPIROX family patents
